ClinicalTrials.gov
ClinicalTrials.gov Menu

A Retrospective Review of Infections Usually Observed in Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00298077
Recruitment Status : Completed
First Posted : March 1, 2006
Last Update Posted : June 12, 2018
Sponsor:
Information provided by (Responsible Party):
EJ Kwak, University of Pittsburgh

Brief Summary:
The study will identify patients with infections commonly observed in transplant recipients, describe the epidemiology of their infection, study the risk factors associated with various infections and examine strategies of early diagnosis and prevention of infection

Condition or disease
Infection

Detailed Description:
The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, previous medical surgical conditions, microbiology and virology culture results, laboratory and radiographical data, antimicrobial usage of onset of infection, microbiological data and resistance patterns, choice of antibiotics once organism identified, suspected source of infection, bacteriological outcomes, laboratory results, demographic information, pathology and histology results, summaries of admissions, discharges, operations, death, medications, clinical outcome gender, height, weight, ethnicity, date of transplant, type of transplant, primary diagnosis, and past medical history. Also required are medical summaries of admissions, discharges, operations, and deaths

Study Type : Observational
Actual Enrollment : 500 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: A Retrospective Review of Infections Usually Observed in Transplant Recipients
Actual Study Start Date : August 2006
Actual Primary Completion Date : June 2017
Actual Study Completion Date : June 2017



Biospecimen Retention:   Samples Without DNA
No genetic testing will be performed on any of the samples being obtained. The biologic samples will be under the control of the principal investigator of this research project. To protect confidentiality, all personal identifiers (i.e., name, social security number, and birth date) will be removed (de-identified) and replaced with a specific code number. The information linking these code numbers to the corresponding subjects' identities will be kept in a separate, secure location. The investigators on this study will keep the samples indefinitely. If a subject withdraws and provides the request in writing, samples collected and not already processed will be destroyed. All samples will be kept in the investigator's laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
transplant recipients with infections
Criteria

Inclusion Criteria:

  • Patients who receive medical care at UPMC
  • Patients who developed infections usually observed in transplant recipients

Exclusion:

  • Patients who do not receive medical care in UPMC Oakland campus

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00298077


Locations
United States, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
UPMC
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Eun Kwak, MD University of Pittsburgh

Responsible Party: EJ Kwak, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00298077     History of Changes
Other Study ID Numbers: IRB# 0602053
First Posted: March 1, 2006    Key Record Dates
Last Update Posted: June 12, 2018
Last Verified: June 2018

Keywords provided by EJ Kwak, University of Pittsburgh:
Infection
transplant recipients

Additional relevant MeSH terms:
Infection
Communicable Diseases